Воздействие розувастатина (Мертенила) на факторы риска у лиц с артериальной гипертензией

Суджаева Ольга Александровна, С Г Суджаева, Т С Губич et al. · Международные обзоры: клиническая практика и здоровье · 2014

The review of modern European recommendations on management of dyslipidemiya, hypertension and secondary prevention is provided in article. This review is devoted to value of different risk factors and to possibility of their correction. Authors described their own results of research of prevalence of a homocysteinemia at patients with hypertension and possibilities of its correction with rosuvastatin (Mertenil, Gideon Richter, Hungary).

Cited by 0 works.

Authors